Among the AR-regulated genes in both LNCaP and VCaP (LNCaP/VCaP), the number of genes significantly upregulated (P < 0.05) in prostate cancer tissues compared to benign prostate tissues was high (13.8%). This evidence concerns the gene AR and prostate carcinoma.